ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,00%
Bitcoin
66.975,28
-0,16%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Manhattan Pharmaceuticals (MHA)

  7. Manhattan Pharmaceuticals (MHA) News

MHA

Manhattan Pharmaceuticals (MHA)

Manhattan Pharmaceuticals
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:MHA
DatumZeitQuelleÜberschriftSymbolFirma
19/03/200817h35Edgar (US Regulatory)Manhattan Pharmaceuticals Inc-Amended Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/re.. (25/A)AMEX:MHAManhattan Pharmaceuticals
10/03/200819h14Edgar (US Regulatory)Manhattan Pharmaceuticals Inc-Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/retired sec. (25)AMEX:MHAManhattan Pharmaceuticals
05/03/200822h19Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)AMEX:MHAManhattan Pharmaceuticals
28/02/200820h43Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
13/02/200823h12Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)AMEX:MHAManhattan Pharmaceuticals
06/02/200823h00Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
03/01/200820h56Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
10/12/200713h07Business WireAMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance with Continued Listing StandardsAMEX:MHAManhattan Pharmaceuticals
14/11/200716h00Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:MHAManhattan Pharmaceuticals
03/10/200722h02Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
03/10/200722h02Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
21/09/200720h35Edgar (US Regulatory)Manhattan Pharmaceuticals Inc (Other) (8-K)AMEX:MHAManhattan Pharmaceuticals
10/07/200713h00PR Newswire (US)Manhattan Pharmaceuticals Provides Update on Clinical PipelineAMEX:MHAManhattan Pharmaceuticals
09/07/200722h30PR Newswire (US)Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estroneAMEX:MHAManhattan Pharmaceuticals
27/06/200714h59PR Newswire (US)Manhattan Pharmaceuticals Acquires Hedrin(TM) for the Treatment of Head LiceAMEX:MHAManhattan Pharmaceuticals
10/05/200715h29PR Newswire (US)Manhattan Pharmaceuticals Successfully Completes Dosing Portion of Two Phase 2a Clinical Trials of Oral Oleoyl-estrone for ObesiAMEX:MHAManhattan Pharmaceuticals
04/04/200715h29PR Newswire (US)Manhattan Pharmaceuticals Announces License Agreement and Expanded PipelineAMEX:MHAManhattan Pharmaceuticals
02/04/200715h29PR Newswire (US)Manhattan Pharmaceuticals Completes $8.6 Million Private PlacementAMEX:MHAManhattan Pharmaceuticals
27/03/200715h29PR Newswire (US)AMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance With Continued Listing StandardsAMEX:MHAManhattan Pharmaceuticals
21/02/200714h29PR Newswire (US)Manhattan Pharmaceuticals Completes Enrollment in Phase 2a Study of Oral Oleoyl-estrone for ObesityAMEX:MHAManhattan Pharmaceuticals
08/11/200614h29PR Newswire (US)Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to USAMEX:MHAManhattan Pharmaceuticals
08/11/200614h29PR Newswire (US)Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to USAMEX:MHAManhattan Pharmaceuticals
12/10/200615h29PR Newswire (US)Manhattan Pharmaceuticals Expanding Oral Oleoyl-estrone Clinical Program to Include Morbidly ObeseAMEX:MHAManhattan Pharmaceuticals
29/06/200617h29PR Newswire (US)Manhattan Pharmaceuticals Doses First Patient Group In Phase IIa Trial For OE, Its Oral Obesity Drug CandidateAMEX:MHAManhattan Pharmaceuticals
16/05/200615h02PR Newswire (US)Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug CandidateAMEX:MHAManhattan Pharmaceuticals
28/12/200517h25PR Newswire (US)Manhattan Pharmaceuticals' Topical Psoriasis Treatment in Phase IIa TrialAMEX:MHAManhattan Pharmaceuticals
07/10/200519h35PR Newswire (US)American Stock Exchange Lists Common Stock of Manhattan Pharmaceutical Inc.AMEX:MHA
 Showing the most relevant articles for your search:AMEX:MHA

Kürzlich von Ihnen besucht

COIN
RUPXOGBP
USOTC
ITKSF
Independent Tankers (CE)
COIN
ETHUSD
Ethereum
LSE
AMA
Amara
NASDAQ
OPTXW
Syntec Optics
COIN
KXCUSD
KingXChain
EU
BE0002799808
KBC Group NV Domestic bo...
BIT
P1BWE5
BNP Paribas Issuance
NYSE
CMO-A.CL
BIT
A05144
Aldburg Public
BIT
P12V54
BNP PARIBAS ISSUANCE
BIT
UC1C53
Unicredit Bank
COIN
BIGUPEUR
NASDAQ
ONAV
UNSW
RADETH
Radicle
NASDAQ
CADL
Candel Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten